Playing from staycurrentmd
8 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Update Course Rewind 2025: Botox for Hirschsprung’s: Where, When, and Why

Video Published 2026-05-15 Updated 2026-06-10

Timestops (5)

Topic Overview

This presentation examines the use of botulinum toxin injection during pull-through surgery for Hirschsprung disease. Cincinnati Children's data shows Botox administration reduced 30-day enterocolitis risk from 30% to 0%, though optimal dosing and injection technique remain unstandardized across centers.

Key Takeaways

  • Only 24% of surgeons inject Botox during Hirschsprung pull-through procedures, with practice varying widely across centers
  • Botox injection at pull-through reduced 31-day enterocolitis risk from 30% to 0% in Cincinnati Children's 2020-2024 study
  • Optimal Botox dosing for Hirschsprung procedures remains unstudied; evidence-based protocols are needed
  • Ultrasound guidance allows precise visualization of injection depth and diffusion but requires operator comfort with technique
  • Botox use during pull-through increases diaper rash incidence but may prevent more serious enterocolitis complications

Keywords

Hashtags

Transcript

Comments

Loading comments…